Assessing satisfaction with desloratadine and fexofenadine in allergy patients who report dissatisfaction with loratadine

BACKGROUND: The FDA recently moved loratadine (Claritin) from prescription only status to over-the-counter (OTC). In response to the availability of an OTC non-sedating antihistamine, many managed care organizations are reevaluating which if any prescription antihistamines should remain on formulary...

Descripción completa

Detalles Bibliográficos
Autores principales: Glass, Daniel J, Harper, Anne S
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC194638/
https://www.ncbi.nlm.nih.gov/pubmed/12917016
http://dx.doi.org/10.1186/1471-2296-4-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC194638/
https://www.ncbi.nlm.nih.gov/pubmed/12917016
http://dx.doi.org/10.1186/1471-2296-4-10

Ejemplares similares